1.	Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma Phase: Phase IV Type: Treatment Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: 0559/07, NCT00803907
2.	Cure Rates of Superficial Basal Cell Carcinom (BCC) Following 1 Versus 3 Cycles of Electrodessication and Curettage (ED&C) Phase: Phase IV Type: Treatment Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: H-2007-0252, PRMC_CO08303, NCT00994240
3.	Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses Phase: Phase IV Type: Prevention, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 10-0933, NCT01229319
4.	Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Mann-Cohen Version 2, NCT01459666
5.	Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients Phase: Phase IV Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: IPDTAKOTR/V06/28.12.11, NCT01538901
6.	Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis Phase: Phase IV Type: Prevention, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: ISD-FPT-01-2012, NCT01656226
7.	Fractional CO2 Laser Assisted Photodynamic Therapy Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: H-1-2010-044, 2010-020179-22, NCT01260987
8.	A Randomized Control Trial of Sun Protection Interventions for Operating Engineers Phase: Phase III, Phase II Type: Prevention Status: Active Age: Over 18 Sponsor: Other Protocol IDs: N015454-00, NCT01804595
9.	Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: TROG 05.01, NCT00193895
10.	Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 01, NCT00663650
11.	CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: 2007.489/32, NCT00799188
12.	5fluorouracil for Advanced Photoaging Phase: Phase III Type: Treatment Status: Active Age: 50 to 75 Sponsor: Other Protocol IDs: Carol2011, NCT01405144
13.	Investigate the Diagnostic Value and Possibilities of OCT in Non-Melanoma Skin Cancer. Phase: Phase II, Phase I Type: Diagnostic Status: Active Age: Over 18 Sponsor: Other Protocol IDs: oct-MM-2005, Grant # BIOPHOT 26-02-0020, NCT00390351
14.	Non-comparative Trial Exploring Efficacy and Safety of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma (nBCC) Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: SP848-nBCC-1104, NCT01808950
15.	Phase II Study of Intralesional Photodynamic Therapy Using Aminolevulinic Acid and Non-Coherent Blue Light in Patients With Basal Cell Carcinoma. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Treatment Status: Active Age: 30 and over Sponsor: Pharmaceutical / Industry Protocol IDs: DUSA-PDT-BCC-06, DUSA-PDT-BCC-06, NCT00747903
16.	A Study in Head and Neck Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 13420, I4E-MC-JXBB, NCT01063075
17.	Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC) Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Luc 09-002, NCT01129154
18.	Study of Erlotinib in the Treatment of Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) of the Skin Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2009-0888, NCT01198028
19.	Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010-024517-31, NCT01349361
20.	Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CLDE225B2209, 2010-023819-34, NCT01350115
21.	A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MO25616, 2011-000195-34, NCT01367665
22.	Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Phase: Phase II Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: ENT0033, SU-08222011-8290, 22329, NCI-2011-03271, NCT01437449
23.	Vismodegib for Treatment of Basal Cell Carcinoma Phase: Phase II Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 5110325, NCT01543581
24.	Trial Comparing the Effects of Intermittent Vismodegib Versus Photodynamic Therapy in Patients With Multiple Basal Cell Carcinomas Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2011-077, ML28244, NCT01556009
25.	Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SZ10ON03, NCT01666431